Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 6, 2011Clinical and Experimental Pharmacology and Physiology

Human epicardial fat: what is new and what is missing?

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

HSHarold S. SacksRegeneron (United States)JFJohn N. FainUniversity of Tennessee Health Science Center

Discussion

Loading...

Member takes

Overview

EAT measurement should not yet guide AMI risk stratification in obese patients; leaves open its incremental prognostic value beyond established factors.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sacks et al. (2011) studied this question.

synapsesocial.com/papers/6a70c5815671bbf00bc2c489https://doi.org/10.1111/j.1440-1681.2011.05601.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adipokine concentrations are similar in femoral artery and coronary venous sinus blood: evidence against in vivo endocrine secretion by human epicardial fat2009 · 5 citations
  2. 2Visceral Fat in Hypertension2004 · 274 citations
  3. 3Epicardial Adipokines in Obesity and Coronary Artery Disease Induce Atherogenic Changes in Monocytes and Endothelial Cells2010 · 166 citations
  4. 4Association of Pericardial Fat With Liver Fat and Insulin Sensitivity After Diet‐Induced Weight Loss in Overweight Women2010 · 45 citations
  5. 5Pericardial and Visceral Adipose Tissues Measured Volumetrically With Computed Tomography Are Highly Associated in Type 2 Diabetic Families2005 · 149 citations